Skip to main content

Creatine Deficiency, X-linked clinical trials at UCSD
1 in progress, 1 open to new patients

  • Observational Study of Males With Creatine Transporter Deficiency

    open to eligible males ages 6 months to 65 years

    With only limited prospective longitudinal data currently available on Creatine Transporter Deficiency (CTD), its natural history is at present incompletely understood. This international study is designed to provide additional insights into disease progression, to characterize how patients perform on clinical neurodevelopmental assessments, and to evaluate magnetic resonance spectroscopy (MRS) and event-related potentials (ERPs) in patients with CTD.

    La Jolla, California and other locations